Xtx Topco LTD Cor Medix Inc. Transaction History

Xtx Topco LTD

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	BUY	$3.6 - $4.46 $55,483 - $68,737	15,412 New	15,412 $57,000
Q3 2022 Nov 14, 2022	BUY	$2.82 - $7.52 $176,075 - $469,533	62,438 Added 516.02%	74,538 $211,000
Q2 2022 Aug 15, 2022	BUY	$2.73 - $5.61 $33,033 - $67,881	12,100 New	12,100 $49,000

109

17.4M

134K

441K

Ticker CRMD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 41,208,200
Market Cap $502M
Description
CorMedix Inc., a biopharmaceutical company, focuses on developing and commercializing therapeutic products for the prevention and treatment of infectious and inflammatory diseases in the United States and internationally. Its lead product candidate is DefenCath/Neutrolin, a novel anti-infective solution for the reduction and prevention of cathet...

Get notified when there are updates to the investment portfolio of Xtx Topco LTD, based on Form 13F filings with the SEC.

Stay updated on Xtx Topco LTD with notifications on news.